ARCA biopharma sets 2022 annual meeting for Dec 15, record date Oct 25

Oruka Therapeutics, Inc.

Shareholder proposals/nominations due by Oct 24, 2022 due to meeting being >30 days from prior year.
Proxy materials expected to be available on or about Nov 4, 2022.
Record date for voting set as Oct 25, 2022.

item 5.08 item 9.01

Oruka Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-034773

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.